News

World’s first leadless pacemaker honored by electrophysiology community as most innovative product at Cardiostim 2014 ST. PAUL, Minn. & NICE, France--(BUSINESS WIRE)--St. Jude Medical, Inc., a global medical device company, announced the...

Study Supplements Earlier Data Showing Reduction in Hospital Readmissions for Heart Failure Patients with AdaptivCRT Technology MINNEAPOLIS, USA and NICE, FRANCE - June 18, 2014 - New data from the Medtronic, Inc. Adaptive CRT trial show a...

Qubic Stim Represents 30 Years of Quality for the Device Manufacturer NICE, France, June 16, 2014 – BIOTRONIK, a leading manufacturer of cardiovascular medical technology, is presenting its new heart stimulator at the Cardiostim 2014...

Los Altos, CA – June 9, 2014 - ScImage, Inc., a leading provider of on premises, in the cloud or hybrid healthcare enterprise imaging and clinical workflow solutions has announced the U.S. government has awarded the company its DIN-PACS III...

eCardio Diagnostics, LLC (eCardio), a leader in remote cardiac arrhythmia monitoring services in the United States, and Shandong Yocaly Information Science & Technology Co., Ltd. (Yocaly), a remote, real-time medical cardiac monitoring...

St. Jude Medical, Inc., a global medical device company, announced it has completed its acquisition of privately held CardioMEMS, Inc., developer of the CardioMEMS™ HF System. The acquisition was completed on May 30, 2014. Commenting on the...

Single-chamber Devices Receive CE Mark for Full Body MRI Scans Without Positioning Restrictions Medtronic, Inc., announced CE (Conformité Européenne) Mark and commercial launch of the Advisa® and Ensura SR MRI™ SureScan® single chamber...

St. Jude Medical, Inc., a global medical device company, and CardioMEMS, announced U.S. Food and Drug Administration (FDA) approval of the CardioMEMS™ HF System. The CardioMEMS HF System is the first and only FDA-approved heart failure (HF)...

LAKE OSWEGO, Oregon, May 22, 2014 – BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today that the Food and Drug Administration (FDA) has approved a significant expansion of its ongoing ProMRI® trial. The...